Skip to main content
Move the World.
horse antibodies for covid 19

Lead Image © virgonira / Adobe Stock

With the swirl of excitement around drugmaker Eli Lilly's monoclonal antibody treatment — reported to reduce the severity of COVID-19 — scientists in Costa Rica are looking to create a cheaper, easier-to-manufacture version: using horse antibodies for COVID-19.

Horse blood has a surprisingly long history in human medicine. For over a century, horses, sheep, and other large animals have been inoculated with snake venom, with the resulting robust antibodies purified from their blood and administered as antivenom. 

Much like antibodies against viruses, these equine antibodies bind to venom from snakes, scorpions, spiders, and fish, arresting damage and potentially saving a victim's life.

Using the same method, researchers in Costa Rica are preparing a clinical trial of horse antibodies against COVID-19; if the antibodies prove effective, they could become a relatively cheap weapon to help hold off SARS-CoV-2, especially in low and middle income countries.

And They're Off!

Horse antibodies for COVID-19 are created the same way as humans', from exposure to the virus. Antivenom specialists at the University of Costa Rica's Clodomiro Picado Institute inoculated six donated horses with proteins from the coronavirus.

Three of the horses received only a protein related to SARS-Cov-2's dreaded spike protein, Scientific American reports; the other three got that protein, along with three others. After letting the equine immune system do its thing for a few weeks, the researchers drew their blood and separated out the horse antibodies for COVID-19.

Those antibodies were sent to the National Center for Biodefense and Infectious Disease at George Mason University. "We wanted to determine if the SARS-CoV-2 virus could be neutralized by the horse-produced antibodies," Center executive director Charles Bailey told Scientific American.

"We exposed the antibodies produced in horses, at various dilutions, to the SARS-CoV-2 virus growing on cell culture. The virus was neutralized."

While obviously good news, stopping the virus in a petri dish is, alas, not the same as stopping it in the wild, in humans. Which is why the next step is a clinical trial, where the horse antibodies are going to be tested on 26 patients, beginning in mid-September, Reuters reports. If the results look promising, the project hopes to expand to a larger trial in the nations's hospitals.

A Horse Is the Source, Of Course Of Course

Eli Lilly's much ballyhooed treatment uses what are called monoclonal antibodies; these are manufactured proteins that act like naturally produced antibodies. They're sometimes used to treat cancers and other ailments, but are difficult and expensive to produce. They require a complex process using bacteria that can take two to four weeks, according to the New York Times, and special facilities are needed to create them.

By comparison, horse antibodies for COVID-19 would be easier and cheaper to produce. Monoclonal antibodies are designed to hone in on one specific target, while the horse's antibodies attack many — less precision means easier manufacturing, which means a more affordable treatment. (But that may also mean less efficacy.)

"Here, the horses are the factories — at least for the production part," public health expert Román Macaya told Scientific American. "Then comes the purification part, which is an industrial process, but the Clodomiro Picado Institute already has that infrastructure."

Horse antibodies for COVID-19 would be easier and cheaper to produce than monoclonal antibodies.

Clodomiro Picado Institute COVID-19 lead researcher Alberto Alape Girón estimated a vial of horse antibodies for COVID-19 would cost about $100, Scientific American reports; in comparison, a vial of monoclonal antibodies could be ten times as expensive.

Horses make a ton of antibodies compared to people, as well.

"Just one 10-mL vial has about 80 times the quantity of antibodies you can find in 800 mL of convalescent plasma, which is the plasma donated by someone who has overcome an infection of SARS-CoV-2," Alape-Girón told Scientific American.

Essentially, the well-known processes developed to create antivenoms (and the animals' ubiquity) make horse antibodies for COVID-19 an attractive option.

All of this hinges on the human trials, of course; we're dealing with a superb predator in SARS-CoV-2, and even if they do prove effective, equine antibodies will be a treatment, not a cure. But being able to fight COVID-19 within their own borders would be a source of pride in Costa Rica.

"We are proud to know that this product will save lives until the vaccine reaches the population," Clodomiro Picado Institute project coordinator Alberto Alape told Reuters.

"We do it with our resources, without having to stand in line or compete against other countries, as can be seen with possible vaccines."

Up Next

If you want to understand a problem, talk to the people working on solutions. Join us as we meet the people and explore the ideas on the frontlines of an unprecedented global response.

Coronavirus
Researchers Found Tiny COVID-19 Antibodies In An Alpaca
nanobodies
Coronavirus
Researchers Found Tiny COVID-19 Antibodies In An Alpaca
Inside an alpaca’s blood, researchers have found tiny antibodies — nanobodies — that may lead to future antiviral medications.

Inside an alpaca’s blood, researchers have found tiny antibodies — nanobodies — that may lead to future antiviral medications.

Coronavirus
Patients Report Sudden Hearing Loss From COVID-19
Hearing Loss From COVID-19
Coronavirus
Patients Report Sudden Hearing Loss From COVID-19
Patients are experiencing sudden hearing loss from COVID-19, but if caught early enough, doctors can prevent the problem from becoming permanent.

Patients are experiencing sudden hearing loss from COVID-19, but if caught early enough, doctors can prevent the problem from becoming permanent.

Coronavirus
“Antibody Inhaler” Could Rapidly Treat—and Prevent—COVID-19
antibody inhaler
Coronavirus
“Antibody Inhaler” Could Rapidly Treat—and Prevent—COVID-19
Scientists have discovered a new antibody therapy that can be inhaled to provide treatment and temporary immunity to the coronavirus.
By Sarah Wells

Scientists have discovered a new antibody therapy that can be inhaled to provide treatment and temporary immunity to the coronavirus.

Coronavirus
Is the Coronavirus Airborne, and Does It Matter?
Is the Coronavirus Airborne
Coronavirus
Is the Coronavirus Airborne, and Does It Matter?
Is the coronavirus airborne? More than 200 scientists have told the WHO that yes, it’s likely the coronavirus spreads through aerosols.

Is the coronavirus airborne? More than 200 scientists have told the WHO that yes, it’s likely the coronavirus spreads through aerosols.

Public Health
Blood Enzyme Could Explain Severe Impact of Coronavirus in Men
Coronavirus in Men
Public Health
Blood Enzyme Could Explain Severe Impact of Coronavirus in Men
A new study suggests that higher concentrations of the ACE2 blood enzyme could explain the particularly deadly impact of the coronavirus in men.

A new study suggests that higher concentrations of the ACE2 blood enzyme could explain the particularly deadly impact of the coronavirus in men.

Public Health
Scientists Find a Way to Quickly ID Coronavirus Mutations
coronavirus mutations
Public Health
Scientists Find a Way to Quickly ID Coronavirus Mutations
A new tool that allows scientists to quickly identify coronavirus mutations could help experts track and treat COVID-19.

A new tool that allows scientists to quickly identify coronavirus mutations could help experts track and treat COVID-19.

Public Health
Major League Baseball Joins Massive Coronavirus Antibody Study
Coronavirus Antibody Study
Public Health
Major League Baseball Joins Massive Coronavirus Antibody Study
More than 10,000 Major League Baseball players and employees agreed to have their blood tested for a massive coronavirus antibody study.

More than 10,000 Major League Baseball players and employees agreed to have their blood tested for a massive coronavirus antibody study.

Public Health
It's Safe to Order Takeout During the Coronavirus Pandemic. Here's Why.
Order Takeout During the Coronavirus
Public Health
It's Safe to Order Takeout During the Coronavirus Pandemic. Here's Why.
Many experts agree that you can safely order takeout during the coronavirus pandemic — you just need to follow these steps.

Many experts agree that you can safely order takeout during the coronavirus pandemic — you just need to follow these steps.

Public Health
New App Uses Location Data to Track the Coronavirus
track the coronavirus
Public Health
New App Uses Location Data to Track the Coronavirus
Researchers from MIT and Harvard have created a smartphone app to track the coronavirus, and it puts a premium on user privacy.

Researchers from MIT and Harvard have created a smartphone app to track the coronavirus, and it puts a premium on user privacy.